Copyright
©The Author(s) 2020.
World J Hepatol. Sep 27, 2020; 12(9): 558-573
Published online Sep 27, 2020. doi: 10.4254/wjh.v12.i9.558
Published online Sep 27, 2020. doi: 10.4254/wjh.v12.i9.558
Marker | Comparison groups | Sensitivity | Specificity | AUC | Ref. |
AFP | Meta-analysis | 51.9 | 94 | 0.81 | Xu et al[17] |
AFP-L3 | Meta-analysis | 48.3 | 92.9 | 0.76 | Yi et al[21] |
DCP | Meta-analysis | 71 | 84 | 0.89 | Zhu et al[25] |
Glypican-3 | Meta-analysis | 55 | 58 | 0.78 | Xu et al[34] |
AKR1B10 | HCC vs controls | 72.7 | 95.7 | 0.9 | Ye et al[36] |
HMGB3 | HCC vs controls | 75.6 | 85.6 | 0.79 | Zheng et al[41] |
GALAD | HCC vs controls | 91.6 | 89.7 | 0.97 | Berhane et al[49] |
- Citation: Singh G, Yoshida EM, Rathi S, Marquez V, Kim P, Erb SR, Salh BS. Biomarkers for hepatocellular cancer. World J Hepatol 2020; 12(9): 558-573
- URL: https://www.wjgnet.com/1948-5182/full/v12/i9/558.htm
- DOI: https://dx.doi.org/10.4254/wjh.v12.i9.558